Related Experiment Video
Updated: Jul 6, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Human Parechovirus Central Nervous System Infection in a Young Infant Cohort
Aspasia Katragkou1,2, Avni Sheth3, Christina Gagliardo1,2
1From the Infectious Diseases Division, Department of Pediatrics, Atlantic Health System, Goryeb Children's Hospital, Morristown, New Jersey.
Insights
A 2022 surge of pediatric human parechovirus (HPeV) central nervous system infections in infants showed similar clinical features. This highlights the need for better treatment evaluation and standardized follow-up for long-term prognosis.
Area of Science:
- Pediatric infectious diseases
- Virology
- Neurology
Background:
- Human parechovirus (HPeV) infections can cause severe central nervous system (CNS) disease in infants.
- A notable increase in pediatric HPeV CNS infections occurred in 2022 at our institution.
Purpose of the Study:
- To describe the clinical features of HPeV CNS infections during a 2022 surge.
- To emphasize the need for improved treatment strategies and long-term outcome assessment for affected infants.
Main Methods:
- Retrospective case review of infants diagnosed with HPeV CNS infections.
- Clinical data analysis including symptoms, severity, and outcomes.
Main Results:
- The 2022 surge involved a significant increase in HPeV CNS infection cases.
- Clinical presentations remained consistent with previous years despite the surge.
- No new or unusual clinical manifestations were identified during the surge.
Conclusions:
- The clinical course of HPeV CNS infections in infants did not change during the 2022 surge.
- Further research into treatment efficacy and standardized follow-up protocols is crucial.
- Understanding long-term prognosis for infants with HPeV infection requires ongoing investigation.
Abstract:
In 2022, a surge in cases of pediatric human parechovirus (HPeV) central nervous system infections in young infants was seen at our institution. Despite the dramatic increase in the number of cases seen that year, the clinical features of the illness were similar to prior years. The recent pediatric HPeV surge highlights the need to evaluate treatment options and standardize follow-up to better understand the long-term prognosis of infants with HPeV infection.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Viral Meningitis
Poliomyelitis
Arboviral Encephalitis
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Encephalitis ll: Pathophysiology